Gram-negativeBacilliRespiratory

Haemophilus influenzae

Encapsulated (notably serotype b) Gram-negative coccobacillus causing meningitis, epiglottitis, and pneumonia, primarily in unvaccinated children.

Organism Card

DomainMust know
Identity
  • G−ve coccobacillus (pleomorphic short rod) [1]
  • Family Pasteurellaceae; facultative anaerobe
  • Typeable strains (a–f): type b (Hib) = most virulent, capsulated [1][2]
  • Non-typeable (NTHi): unencapsulated; mucosal pathogen
Lab discriminator
  • Requires factor X (hemin) and factor V (NAD) for growth → grows on chocolate agar, NOT blood agar
  • Satellitism: grows around S. aureus colonies on blood agar (provides factors X + V)
  • Oxidase variable; catalase +
  • Vs M. catarrhalis: latter is oxidase +, diplococcus, β-lactamase almost always +
  • Vs N. meningitidis: latter is G−ve diplococci, maltose +, grows on Thayer-Martin
Reservoir / transmission
  • Human-only nasopharyngeal commensal (no animal reservoir)
  • Droplet / direct contact transmission
  • NTHi colonises upper airway → common in elderly / COPD [7]
  • Hib carriage reduced dramatically post-vaccination
Key virulence
  • Polyribosyl-ribitol phosphate (PRP) capsule (type b): anti-phagocytic, key to invasive disease [2]
  • IgA protease → cleaves mucosal IgA, aids colonisation
  • LOS (lipo-oligosaccharide) endotoxin → inflammatory damage
  • Biofilm formation (NTHi) → chronic otitis media, bronchiectasis persistence
Clinical syndromes
  • Hib (capsulated): meningitis (children, abrupt onset after URTI, mortality < 5%), epiglottitis (classic 2–4 y/o, now 6–12 y/o post-vaccine), pneumonia, cellulitis (buccal/periorbital), osteomyelitis, septic arthritis (children < 2y), bacteraemia [2][3][5]
  • NTHi (non-typeable): sinusitis, otitis media, acute exacerbation of COPD/bronchiectasis (commonest bacterial isolate in early/mild bronchiectasis [7]), conjunctivitis, CAP (especially elderly / underlying lung disease) [6]
  • HACEK group member → rare cause of IE with large vegetations, difficult to isolate [1][4]
  • Encapsulated → susceptible in asplenic / complement-deficient patients (C3, C5-C9 deficiency) [8][9]
Diagnosis
  • Specimen: CSF, blood, sputum, middle ear fluid as appropriate
  • Gram stain of CSF: G−ve coccobacilli (sensitivity 60–90%)
  • Culture on chocolate agar (NOT blood agar); 5–10% CO₂
  • Latex agglutination / CSF antigen for Hib capsular polysaccharide (rapid test)
  • Blood culture (3 sets) for bacteraemia / IE
  • Pitfall: NTHi often regarded as "normal flora" in sputum — correlate with clinical context
Treatment
  • Amoxicillin for susceptible NTHi respiratory infections [6]
  • Augmentin (amoxicillin-clavulanate) or cefotaxime/ceftriaxone for β-lactamase producers and invasive disease [3][6]
  • Meningitis: 3rd-gen cephalosporin (ceftriaxone/cefotaxime) at meningitic dose ×7 days [10]
  • Epiglottitis: Augmentin + 3rd-gen cephalosporin ×≥10 days; airway protection paramount [3]
  • Key resistance: ~20–40% produce β-lactamase → amoxicillin resistance; rare BLNAR strains (β-lactamase-negative ampicillin-resistant)
Prevention
  • Hib conjugate vaccine (PRP-protein conjugate): effective against invasive type b disease [1][2]
  • HK: Hib NOT in Childhood Immunisation Programme (lower incidence vs West) — available in private only [2][5]
  • Pre-/post-splenectomy vaccination: Hib vaccine mandatory (+ pneumococcal, meningococcal, influenza) [8][9]
  • Chemoprophylaxis: rifampicin 20 mg/kg OD ×4 days for index case and close unvaccinated contacts < 5 y (except pregnant women) [10]
  • Post-splenectomy patients: early Abx for febrile episodes (e.g. augmentin) [8]
Classic traps
  • Child fully vaccinated per HK CIP with pneumonia + empyema → answer is S. pneumoniae serotype 3, NOT Hib (Hib vaccine not in HK CIP) [11]
  • NTHi causes mucosal (non-invasive) disease; Hib causes invasive disease — do NOT conflate
  • Epiglottitis = Hib (children); adults more often S. aureus or GAS
  • Septic arthritis in child < 2y → think Hib; child > 2y/adult → S. aureus
  • HACEK IE: think large vegetation + culture-negative initially → prolonged incubation needed
  • Splenectomy vaccination Q: MMR is NOT needed post-splenectomy (it targets viral, not encapsulated bacteria) [12]

Exam Intelligence

On this page

No Headings